|
Global Med Technologies®, Inc. to Present at the
Noble Financial MAD MAX Equity Conference
Global Med Technologies ®, Inc. (“Global Med” or the “Company”) (OTCBB:GLOB), an international e-Health, medical information technology company, today announced that it will present at the Fourth Annual Noble Financial Equity Conference at 12:30 p.m. (Pacific) on Monday, August 18, 2008 at the Loews Lake Las Vegas Resort, Nevada, in the Road Warrior Room.
Dr. Mick Ruxin, Chairman and CEO of Global Med, will give a presentation regarding the Company’s market positioning, financial performance and strategic direction. Dr. Ruxin will also discuss the recent European acquisition of Inlog, SA, and the U.S. acquisition of eDonor ®. The presentation will be webcast LIVE featuring high-definition, streaming video and PowerPoint slides. Access is available by logging on to the conference website www.noblemadmax.com. It is recommended that interested parties register at least 15 minutes prior to the start of the presentation to ensure timely access.
About Noble Financial
Noble Financial is a privately-held, full-service capital markets firm driven by what is often overlooked by other firms - uncovering the value embedded in the orphaned, undiscovered or misunderstood company. The company focuses on converting market inefficiencies into profit opportunities. Noble Financial supports emerging companies through strategic advice, investment banking, market-making, sales & trading, comprehensive equity research, and the development of institutional support. Noble Financial's equity conferences – 2008 marks their fourth annual - allow for a unique blend of professional and personal interaction among a diverse cross-section of executives. The company has operated for 24 years and has offices in Florida, New York City and Boston.
About Global Med Technologies, Inc.
Global Med Technologies, Inc. is an international e-Health, medical information technology company, providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Current clients of Wyndgate’s products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Wyndgate’s products are also being implemented in sub-Saharan Africa. Together, the SafeTrace Tx advanced transfusion management system and the SafeTrace® donor management system provide Vein-to-Vein® tracking from donor collection to patient transfusion.
For more information about Global Med’s products and services, please call 800-996-3428 or visit www.globalmedtech.com, www.peoplemed.com, www.inlog.com and www.wyndgate.com.
|
Company Contact:
Michael I. Ruxin, M.D.
(303) 238-2000 |
|
Investor Information:
Paul Holm/portfoliopr, Inc.
(212) 999-5585 |
|
This news release may include statements that constitute forward-looking statements, usually containing the words “believe,” “estimate,” “project,” “expects” or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.
**FDA 510(k) clearance required prior to sales in the U.S.
|
|
